Literature DB >> 8511597

Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus.

M M Stimmler1, P M Coletti, F P Quismorio.   

Abstract

To determine the utility of magnetic resonance imaging (MRI) of the brain in diagnosing active neuropsychiatric disease in systemic lupus erythematosus (NP-SLE), a prospective study of 51 hospitalized systemic lupus erythematosus (SLE) patients during 64 separate episodes of suspected NP-SLE was initiated. In addition to standard hematology, chemistry, and serological tests, the workup included MRI in all patients. A computed tomographic scan of the brain was obtained in patients enrolled in the first year of the study. Of the 64 neuropsychiatric episodes, 42 were attributable to NP-SLE and 22 were attributed to causes other than SLE. Neuropsychiatric complaints unrelated to lupus included depression (n = 6), seizures (n = 5), headache (n = 3), altered mental status (n = 2), aseptic meningitis (n = 2), cardiovascular accident (n = 2), transient ischemic attack (n = 1), and vertigo (n = 1). The MRI was abnormal in 34 of 64 (53%) episodes. MRI abnormalities were more common in patients with focal neurological deficits (19/26) than in those without focal findings (15/38; P = .008) and in patients with nephritis (19/24) than in those without renal disease (15/40; P = .002). MRI abnormalities were as frequent in NP-SLE (25/42) as in cases with non-NP-SLE-related causes (9/22). Periventricular increased signal (PIS) was a frequent MRI finding (10/64). Enlargement of the prepontine cistern, an MRI finding not previously described in NP-SLE, was seen (14/64). Both findings were associated with the presence of hypertension and lupus nephritis. PIS similar to that seen in our patients has been described in otherwise healthy elderly individuals with risk factors for stroke, suggesting that vascular abnormalities may be important in the etiology of these lesions. In conclusion, abnormalities in brain MRI occur frequently in NP-SLE, especially in patients with focal neurological deficits. However, the presence of similar MRI abnormalities in SLE patients with neuropsychiatric symptoms and findings with non-SLE-related causes limits the specificity of the MRI for diagnosing NP-SLE.

Entities:  

Mesh:

Year:  1993        PMID: 8511597     DOI: 10.1016/s0049-0172(05)80012-5

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  18 in total

1.  Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Gerlof P Th Bosma; Tom W J Huizinga; Simon P Mooijaart; Mark A Van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Multiple brain calcifications in a patient with systemic lupus erythematosus.

Authors:  Carlos A Cañas; Gabriel J Tobón
Journal:  Clin Rheumatol       Date:  2008-05-28       Impact factor: 2.980

3.  Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.

Authors:  J S Axford; F A Howe; C Heron; J R Griffiths
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Subdural fluid collections: an unusual manifestation of CNS disease in a connective tissue disorder.

Authors:  D J Shaskey; J F Mijer; H J Williams; A D Sawitzke
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

5.  Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus.

Authors:  Yun Lin; Qing-Hua Zou; Jian Wang; Yong Wang; Dai-Quan Zhou; Rong-Hua Zhang; Yan-Wei Zhang; Hai-Tao Lii; Yong-Fei Fang
Journal:  Hum Brain Mapp       Date:  2010-12-17       Impact factor: 5.038

6.  Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.

Authors:  S M Weiner; A Otte; M Schumacher; R Klein; J Gutfleisch; I Brink; P Otto; E U Nitzsche; E Moser; H H Peter
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

7.  Psychosis in a young female - a diagnostic and therapeutic challenge.

Authors:  Sharmin Nizam; Andrew Gough
Journal:  JRSM Short Rep       Date:  2010-08-31

8.  Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.

Authors:  P Colamussi; M Giganti; C Cittanti; L Dovigo; F Trotta; M R Tola; R Tamarozzi; G Lucignani; A Piffanelli
Journal:  Eur J Nucl Med       Date:  1995-01

9.  Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.

Authors:  Mohamed O Olfat; Sulaiman M Al-Mayouf; Mohamed A Muzaffer
Journal:  Clin Rheumatol       Date:  2004-07-23       Impact factor: 2.980

10.  18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.

Authors:  F Grünwald; A Schomburg; A Badali; J Ruhlmann; L Pavics; H J Biersack
Journal:  Eur J Nucl Med       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.